AIM

#5038
AIM ImmunoTech Inc.
0.5800 USD
+7.57%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.5701
0.5840
Rango anual
0.5060
20.3500
Cambio diario
+7.57%
Variación mensual
-22.67%
Variación en los últimos 6 meses
-77.78%
Cambio anual
-93.18%
Cierres anteriores
0.5392
Abrir
0.5701
Bid
Ask
Mínimo
0.5701
High
0.5840
Volumen
22
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 4.7257 M
  • Employee 21
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.13
Relación precio/flujo de caja
20.76

AIM ImmunoTech Inc

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Noticias